NKTI suspends dispensing of remdesivir, tocilizumab due to critical supply | Inquirer News
Close  

NKTI suspends dispensing of remdesivir, tocilizumab due to critical supply

/ 08:54 PM August 31, 2021
NKTI suspends dispensing of remdesivir, tocilizumab due to critical supply

National Kidney and Transplant Institute (NKTI)

MANILA, Philippines — The National Kidney and Transplant Institute (NKTI) in Quezon City said it temporarily suspended the dispensing of remdesivir and tocilizumab to COVID-19 patients outside the hospital due to critical supply.

“Our stock is already critical, and we have not been receiving stock from the supplier,” said  NKTI Director Rose Marie Liquete in an interview with CNN Philippines on Tuesday.

ADVERTISEMENT

According to Liquete, the hospital currently has 115 COVID-positive patients of which most are severe to critical patients and more than half are on dialysis.

Apart from this, 60 patients are still waiting in the hospital’s emergency room.

FEATURED STORIES

“In a few days there will not be enough anymore because every day we are increasing, last week mga 100 lang, 107, today we have 115. If you compute the [needs] of each patient who are severe to critical, ubos lahat yun (nothing is left),” said Liquete.

“If we don’t get the stock from tocilizumab for example within this week, wala na ‘yan (nothing will be left),” she added.

Remdesivir and tocilizumab are drugs used to treat severe to critical COVID-19 cases.

NKTI also previously announced it would stop dispensing hemoperfusion cartridges to non-NKTI patients as their stock of these cartridges is limited as well.

NKTI Public Advisory (29 August 2021)

Posted by National Kidney and Transplant Institute on Sunday, August 29, 2021

ADVERTISEMENT

RELATED STORIES

Stocks of remdesivir, tocilizumab in PH running low – DOH

Gov’t facing challenges in stock of anti-inflammatory drug tocilizumab — DOH

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19, hospital, medicine, NKTI, pandemic, remdesivir, tocilizumab 
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.